JAAPA CME Post-Test July 2019

Deprescribing at the End of Life in Older Patients
In the United States, the adult population that will need hospice and palliative care is expected to double in the next 40 years. In primary care, providers are often faced with tough decisions on how to manage patients’ medications at the end of life. This activity describes how to deprescribe in the last year of life.

An Overview of Reactive Arthritis
Reactive arthritis, also known as Reiter syndrome, is a spondyloarthropathy that typically follows a urogenital or gastrointestinal infection, and is characterized by conjunctivitis, urethritis, and arthritis. The frequency of reactive arthritis in the United States is estimated at 3.5 to 5 patients per 100,000. PAs can manage the condition; therefore, they should be familiar with the disease’s signs and symptoms, diagnostic criteria, and treatment regimens. Without proper management, reactive arthritis can progress to a chronic destructive arthritis. Prompt recognition of the condition is key to early intervention and a better patient outcome with fewer complications. This activity outlines the common symptoms and management of reactive arthritis.

AAPA offers no returns or refunds for online CME activities purchased via the AAPA store. All sales are final.